160 related articles for article (PubMed ID: 36894688)
1. Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis.
Potts MA; Mizutani S; Garnham AL; Li Wai Suen CSN; Kueh AJ; Tai L; Pal M; Strasser A; Herold MJ
Cell Death Differ; 2023 Jun; 30(6):1447-1456. PubMed ID: 36894688
[TBL] [Abstract][Full Text] [Related]
2. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
3. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
4. Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytes.
Tonc E; Takeuchi Y; Chou C; Xia Y; Holmgren M; Fujii C; Raju S; Chang GS; Iwamoto M; Egawa T
Blood; 2021 Dec; 138(24):2526-2538. PubMed ID: 34283887
[TBL] [Abstract][Full Text] [Related]
5. Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis.
Grabow S; Delbridge AR; Aubrey BJ; Vandenberg CJ; Strasser A
Cell Rep; 2016 Mar; 14(10):2337-47. PubMed ID: 26947081
[TBL] [Abstract][Full Text] [Related]
6. Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells.
Mensink M; Anstee NS; Robati M; Schenk RL; Herold MJ; Cory S; Vandenberg CJ
Cell Death Differ; 2018 Mar; 25(4):797-808. PubMed ID: 29339775
[TBL] [Abstract][Full Text] [Related]
7. Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis.
Grabow S; Kelly GL; Delbridge AR; Kelly PN; Bouillet P; Adams JM; Strasser A
Cell Death Dis; 2016 Mar; 7(3):e2132. PubMed ID: 26962682
[TBL] [Abstract][Full Text] [Related]
8. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
[TBL] [Abstract][Full Text] [Related]
9.
Mathsyaraja H; Freie B; Cheng PF; Babaeva E; Catchpole JT; Janssens D; Henikoff S; Eisenman RN
Genes Dev; 2019 Sep; 33(17-18):1252-1264. PubMed ID: 31395740
[TBL] [Abstract][Full Text] [Related]
10. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.
Michalak EM; Jansen ES; Happo L; Cragg MS; Tai L; Smyth GK; Strasser A; Adams JM; Scott CL
Cell Death Differ; 2009 May; 16(5):684-96. PubMed ID: 19148184
[TBL] [Abstract][Full Text] [Related]
11. Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma.
Winkler R; Piskor EM; Kosan C
Cells; 2022 Dec; 12(1):. PubMed ID: 36611833
[TBL] [Abstract][Full Text] [Related]
12. IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.
Vecchio E; Fiume G; Mignogna C; Iaccino E; Mimmi S; Maisano D; Trapasso F; Quinto I
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019112
[TBL] [Abstract][Full Text] [Related]
13. Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas.
Nepal RM; Tong L; Kolaj B; Edelmann W; Martin A
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18698-703. PubMed ID: 19837692
[TBL] [Abstract][Full Text] [Related]
14. MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis.
Nguyen HV; Vandenberg CJ; Robati MR; Ng AP; Cory S
Cell Death Differ; 2023 Apr; 30(4):1018-1032. PubMed ID: 36755068
[TBL] [Abstract][Full Text] [Related]
15. Loss of PRDM11 promotes MYC-driven lymphomagenesis.
Fog CK; Asmar F; Côme C; Jensen KT; Johansen JV; Kheir TB; Jacobsen L; Friis C; Louw A; Rosgaard L; Øbro NF; Marquart HV; Anthonsen K; Braat AK; van Lohuizen M; Ralfkiaer E; Grønbæk K; Lund AH
Blood; 2015 Feb; 125(8):1272-81. PubMed ID: 25499759
[TBL] [Abstract][Full Text] [Related]
16. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
[TBL] [Abstract][Full Text] [Related]
17. Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma model.
Borland G; Kilbey A; Hay J; Gilroy K; Terry A; Mackay N; Bell M; McDonald A; Mills K; Cameron E; Neil JC
Oncotarget; 2016 Apr; 7(17):22973-87. PubMed ID: 27056890
[TBL] [Abstract][Full Text] [Related]
18. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes.
Bouquet C; Melchers F
Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984
[TBL] [Abstract][Full Text] [Related]
19. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice.
Galindo-Campos MA; Lutfi N; Bonnin S; Martínez C; Velasco-Hernandez T; García-Hernández V; Martín-Caballero J; Ampurdanés C; Gimeno R; Colomo L; Roué G; Guilbaud G; Dantzer F; Navarro P; Murga M; Fernández-Capetillo O; Bigas A; Menéndez P; Sale JE; Yélamos J
Blood; 2022 Jan; 139(2):228-239. PubMed ID: 34359075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
